What Researchers Did
Researchers investigated how hyperbaric oxygen therapy affected cultured human blood vessel cells in a laboratory model simulating oxygen deprivation followed by reoxygenation.
What They Found
Immediately after 8 hours of anoxia and 1.5 hours of reoxygenation with hyperbaric oxygen, the mean concentrations of fibrinolytic factors t-PA, PAI-1, and uPA were significantly increased compared to cells reoxygenated with normobaric air or untreated controls. This significant difference between the hyperbaric oxygen and normobaric air groups persisted for up to 24 hours post-anoxia.
What This Means for Canadian Patients
These observations suggest that hyperbaric oxygen therapy could potentially stimulate the release of factors that help prevent blood clots or microembolisms following injuries where blood flow is temporarily cut off. This mechanism might be relevant in trauma care, offering a potential benefit for patients recovering from severe injuries by supporting the body's natural clot-dissolving processes.
Canadian Relevance
No direct Canadian connection identified. The study does not involve Canadian authors or institutions, and ischaemia-reperfusion injury in trauma care is not a Health Canada-recognised indication for HBOT.
Study Limitations
A key limitation is that this study was conducted using cultured cells in a laboratory setting, which may not fully reflect how hyperbaric oxygen affects the complex human body.